YS BIOPHARMA CO LTD (YS)

KYG9845F1090 - Common Stock

0.7199  +0.01 (+1.39%)

After market: 0.7055 -0.01 (-2%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
687.201M88.632M
-87.10%
EBITDA
YoY % growth
N/A30.597M-102.695M
-435.63%
-22.739M
77.86%
N/AN/AN/A
EBIT
YoY % growth
-3.64K-556.83K
-15,197.53%
-139.382M
-24,931.40%
-27.919M
79.97%
Operating Margin
N/AN/A-20.28%-31.50%
EPS
YoY % growth
N/AN/AN/A-0.34N/AN/AN/A

All data in CNY

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.80
Revenue
Q2Q % growth
145.61M
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-63.026MN/AN/AN/AN/A

All data in CNY

Recent Earnings VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
-1.13 -0.74-0.39-52.46%
Recent Revenue VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
273.092M
∞%
149.52M123.572M82.65%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -749.87% 0% 0%
Revenue0% 689.34% -85.12% 3.16%